홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Thiazole → Ethyl 4-[(5,6-dihydro-5,5-dimethyl-8-(2-thiazolyl)-2-naphthalenyl)ethynyl]benzoate

HRID 495912
인쇄

반응식

HRID 495912 반응식
[CH2:1]([Li:5])CCC.[S:6]1[CH:10]=[CH:9][N:8]=[CH:7]1.[CH3:11][C:12]1([CH3:42])[CH2:21][CH:20]=[C:19](C2C=CC(C)=CC=2)[C:18]2[CH:17]=[C:16]([C:29]#[C:30][C:31]3[CH:41]=[CH:40][C:34]([C:35]([O:37][CH2:38][CH3:39])=[O:36])=[CH:33][CH:32]=3)[CH:15]=[CH:14][C:13]1=2>C1COCC1.[NH4+].[Cl-].[Cl-].[Zn+2].[Cl-].C1C=CC([P]([Pd]([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)[P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)=CC=1>[Li:5][C:1]1[S:6][CH:10]=[CH:9][N:8]=1.[CH3:42][C:12]1([CH3:11])[CH2:21][CH:20]=[C:19]([C:7]2[S:6][CH:10]=[CH:9][N:8]=2)[C:18]2[CH:17]=[C:16]([C:29]#[C:30][C:31]3[CH:32]=[CH:33][C:34]([C:35]([O:37][CH2:38][CH3:39])=[O:36])=[CH:40][CH:41]=3)[CH:15]=[CH:14][C:13]1=2
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

9

반응물 3

HCID 9256ThiazoleHCID 11796412AGN 193109 Ethyl Ester2회HCID 178418339Butyllithium

생성물 2

HCID 15430593Ethyl 4-[(5,6-dihydro-5,5-dimethyl-8-(2-thiazolyl)-2-naphthalenyl)ethynyl]benzoateHCID 178506781HCID 178506781, 화합물

시약·촉매·용매 4

HCID 3007855
Sinkkikloridi
촉매
HCID 178418397HCID 178418397, 화합물촉매
HCID 8028Tetrahydrofuran용매3회
HCID 25517Ammonium Chloride용매

실험 절차

A solution of 2-lithiothiazole was prepared by the addition of 41.2 mg (0.42 ml, 0.63 mmol) of n-butyl-lithium (1.5M solution in hexanes) to a cold solution (−78 ° C.) of 53.4 mg (0.63 mmol) of thiazole in 1.0 ml of THF. The solution was stirred at for 30 minutes and then a solution of 113.9 mg (0.84 mmol) of zinc chloride in 1.5 ml of THF was added. The resulting solution was warmed to room temperature, stirred for 30 minutes and then the organozinc was added via cannula to a solution of 200.0 mg. (0.42 mmol) of ethyl 4-[(5,6-dihydro-5,5-dimethyl-8-(trifluoromethylsulfonyl)oxy-2-naphthalenyl)ethynyl]benzoate (Compound G) and 12.4 mg (0.01 mmol) of tetrakis(triphenylphosphine)palladium(0) in 1.5 ml of THF. The resulting solution was heated at 50° C. for 45 minutes, cooled to room temperature and diluted with sat aqueous NH4Cl. The mixture was extracted with EtOAc (40 ml) and the combined organic layers were washed with water and brine. The organic phase was dried over Na2SO4 and concentrated in-vacuo to a yellow oil. Purification by column chromatography (silica, 20% EtOAc-hexanes) yielded the title compound as a colorless oil. PMR (CDCl3): δ 1.35 (6H, s), 1.40 (3H, t, J=7.1 Hz), 2.42 (2H, d, J=4.8 Hz), 4.38 (2H, q, J=7.1 Hz), 6.57 (1H, t, J=4.8 Hz), 7.33 (1H, d, J=3.3 Hz), 7.36 (1H, d, J=8.0 Hz), 7.46 (1H, dd, J=1.7, 8.1 Hz), 7.55 (2H, d, J=8.4 Hz), 7.87 (1H, d, J=1.7 Hz), 7.92 (1H, d, J=3.3 Hz), 8.00 (2H, d, J=8.4 Hz).

후처리

  1. stirringstirred for 30 minutes
  2. temperatureThe resulting solution was heated at 50° C. for 45 minutes
  3. temperaturecooled to room temperature
  4. extractionThe mixture was extracted with EtOAc (40 ml)
  5. washthe combined organic layers were washed with water and brine
  6. dry with materialThe organic phase was dried over Na2SO4
  7. concentrationconcentrated in-vacuo to a yellow oil
  8. customPurification by column chromatography (silica, 20% EtOAc-hexanes)

출처 및 근거

ORD 기록
ord-f1106ac494c74b7980529e6c63fbb900
출처 데이터셋
uspto-grants-2005_09
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US06942980B1

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트